249 related articles for article (PubMed ID: 27028849)
1. Pulmonary vasculature in COPD: The silent component.
Blanco I; Piccari L; Barberà JA
Respirology; 2016 Aug; 21(6):984-94. PubMed ID: 27028849
[TBL] [Abstract][Full Text] [Related]
2. Pulmonary vascular abnormalities in chronic obstructive pulmonary disease undergoing lung transplant.
Peinado VI; Gómez FP; Barberà JA; Roman A; Angels Montero M; Ramírez J; Roca J; Rodriguez-Roisin R
J Heart Lung Transplant; 2013 Dec; 32(12):1262-9. PubMed ID: 24263025
[TBL] [Abstract][Full Text] [Related]
3. Pulmonary hypertension in patients with chronic obstructive pulmonary disease: advances in pathophysiology and management.
Barberà JA; Blanco I
Drugs; 2009 Jun; 69(9):1153-71. PubMed ID: 19537834
[TBL] [Abstract][Full Text] [Related]
4. Pulmonary hypertension in chronic obstructive pulmonary disease.
Barberà JA; Peinado VI; Santos S
Eur Respir J; 2003 May; 21(5):892-905. PubMed ID: 12765440
[TBL] [Abstract][Full Text] [Related]
5. Pulmonary hypertension in COPD: pathophysiology and therapeutic targets.
Zakynthinos E; Daniil Z; Papanikolaou J; Makris D
Curr Drug Targets; 2011 Apr; 12(4):501-13. PubMed ID: 21194405
[TBL] [Abstract][Full Text] [Related]
6. Pulmonary vascular involvement in COPD.
Peinado VI; Pizarro S; Barberà JA
Chest; 2008 Oct; 134(4):808-814. PubMed ID: 18842913
[TBL] [Abstract][Full Text] [Related]
7. Hemodynamic and gas exchange effects of inhaled iloprost in patients with COPD and pulmonary hypertension.
Wang L; Jin YZ; Zhao QH; Jiang R; Wu WH; Gong SG; He J; Liu JM; Jing ZC
Int J Chron Obstruct Pulmon Dis; 2017; 12():3353-3360. PubMed ID: 29200842
[TBL] [Abstract][Full Text] [Related]
8. Pulmonary vascular effects of pulsed inhaled nitric oxide in COPD patients with pulmonary hypertension.
Hajian B; De Backer J; Vos W; Van Holsbeke C; Ferreira F; Quinn DA; Hufkens A; Claes R; De Backer W
Int J Chron Obstruct Pulmon Dis; 2016; 11():1533-41. PubMed ID: 27462149
[TBL] [Abstract][Full Text] [Related]
9. Compartment-specific remodeling patterns in end-stage chronic obstructive pulmonary disease with and without severe pulmonary hypertension.
Zeder K; Marsh LM; Avian A; Brcic L; Birnhuber A; Douschan P; Foris V; Sassmann T; Hoetzenecker K; Boehm PM; Kwapiszewska G; Olschewski A; Olschewski H; Kovacs G
J Heart Lung Transplant; 2024 Jul; 43(7):1090-1101. PubMed ID: 38382583
[TBL] [Abstract][Full Text] [Related]
10. [New pathophysiological concepts in pulmonary hypertension in COPD].
Firă-Mladinescu O; Tudorache V; Mihăicuţă S; Cristescu A
Pneumologia; 2003; 52(3-4):188-92. PubMed ID: 18210732
[TBL] [Abstract][Full Text] [Related]
11. Pulmonary hypertension in chronic obstructive pulmonary disease and interstitial lung diseases.
Weitzenblum E; Chaouat A; Canuet M; Kessler R
Semin Respir Crit Care Med; 2009 Aug; 30(4):458-70. PubMed ID: 19634085
[TBL] [Abstract][Full Text] [Related]
12. Pulmonary hypertension in COPD: old and new concepts.
Barberà JA; Peinado VI; Santos S
Monaldi Arch Chest Dis; 2000 Dec; 55(6):445-9. PubMed ID: 11272628
[TBL] [Abstract][Full Text] [Related]
13. Pulmonary hypertension in chronic lung diseases.
Seeger W; Adir Y; Barberà JA; Champion H; Coghlan JG; Cottin V; De Marco T; Galiè N; Ghio S; Gibbs S; Martinez FJ; Semigran MJ; Simonneau G; Wells AU; Vachiéry JL
J Am Coll Cardiol; 2013 Dec; 62(25 Suppl):D109-16. PubMed ID: 24355635
[TBL] [Abstract][Full Text] [Related]
14. Reactive Oxygen Species in COPD-Related Vascular Remodeling.
Zuo L; Chuang CC; Clark AD; Garrison DE; Kuhlman JL; Sypert DC
Adv Exp Med Biol; 2017; 967():399-411. PubMed ID: 29047102
[TBL] [Abstract][Full Text] [Related]
15. Computed tomographic measurement of airway remodeling and emphysema in advanced chronic obstructive pulmonary disease. Correlation with pulmonary hypertension.
Dournes G; Laurent F; Coste F; Dromer C; Blanchard E; Picard F; Baldacci F; Montaudon M; Girodet PO; Marthan R; Berger P
Am J Respir Crit Care Med; 2015 Jan; 191(1):63-70. PubMed ID: 25393421
[TBL] [Abstract][Full Text] [Related]
16. The vascular bed in COPD: pulmonary hypertension and pulmonary vascular alterations.
Sakao S; Voelkel NF; Tatsumi K
Eur Respir Rev; 2014 Sep; 23(133):350-5. PubMed ID: 25176971
[TBL] [Abstract][Full Text] [Related]
17. Pulmonary hemodynamic profile in chronic obstructive pulmonary disease.
Portillo K; Torralba Y; Blanco I; Burgos F; Rodriguez-Roisin R; Rios J; Roca J; Barberà JA
Int J Chron Obstruct Pulmon Dis; 2015; 10():1313-20. PubMed ID: 26203238
[TBL] [Abstract][Full Text] [Related]
18. Phenotypic assessment of pulmonary hypertension using high-resolution echocardiography is feasible in neonatal mice with experimental bronchopulmonary dysplasia and pulmonary hypertension: a step toward preventing chronic obstructive pulmonary disease.
Reynolds CL; Zhang S; Shrestha AK; Barrios R; Shivanna B
Int J Chron Obstruct Pulmon Dis; 2016; 11():1597-605. PubMed ID: 27478373
[TBL] [Abstract][Full Text] [Related]
19. Pulmonary hypertension secondary to chronic obstructive pulmonary disease.
Gologanu D; Stanescu C; Bogdan MA
Rom J Intern Med; 2012; 50(4):259-68. PubMed ID: 23610973
[TBL] [Abstract][Full Text] [Related]
20. Pulmonary hypertension in chronic obstructive pulmonary disease.
Weitzenblum E; Chaouat A; Kessler R
Pneumonol Alergol Pol; 2013; 81(4):390-8. PubMed ID: 23744170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
